Microbubbles improve response to radioembolization in liver cancer

A recent in-human pilot study from Thomas Jefferson University (PA, USA) has shown that responses to transarterial radioembolization in liver cancer can be improved by using ultrasound to pop injected microbubbles. The study is the first to show the benefit of the nanomaterial synergy in liver cancer. Published recently in Radiology, the study describes 28 patients receiving the combination therapy or radioembolization alone. The demonstrated safety and efficacy has invited additional research into the therapy for liver cancer and other cancers, as well as other similar nanomaterial-based research. Transarterial radioembolization has preliminary approval by the US FDA, with other centers...